Status:
COMPLETED
Dyslipidemia Prevalence, Perception, Treatment, and Awareness in the Tunisian Population
Lead Sponsor:
Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose
Collaborating Sponsors:
Biochimie Clinique LR99ES11
Department of Biochemistry, La Rabta Hospital, Tunisia.
Conditions:
Dyslipidemias
Atherosclerosis
Eligibility:
All Genders
25-75 years
Brief Summary
ATERA Survey is a national cross sectional observational study, aiming to determine the prevalence of dyslipidemia and other conventional risk factors for CHD (Coronary Heart Disease), the relationshi...
Detailed Description
ATERA Survey is carried on in a random sampling including 10 000 men and women from the seven regions of Tunisia (Great Tunis, North East, North West, central East, Central West, South East and South ...
Eligibility Criteria
Inclusion
- All subjects
Exclusion
- Prescribed treatment for cancer
- Organ transplantation
- Known auto-immune disease
- Severe liver disease
- Chronic renal failure
- Pregnant women
Key Trial Info
Start Date :
January 4 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2019
Estimated Enrollment :
13610 Patients enrolled
Trial Details
Trial ID
NCT03799185
Start Date
January 4 2016
End Date
August 31 2019
Last Update
January 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ATERA : Association Tunisienne d'Etude & de Recherche sur l'Athérosclérose
Tunis, Tunisia, 1007